Francesca Capotosti

1.2k total citations
17 papers, 809 citations indexed

About

Francesca Capotosti is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Francesca Capotosti has authored 17 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Neurology. Recurrent topics in Francesca Capotosti's work include Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Francesca Capotosti is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Neuroscience and Neuropharmacology Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Francesca Capotosti collaborates with scholars based in Switzerland, United States and Germany. Francesca Capotosti's co-authors include Winship Herr, Stéphanie Hugues, Melody A. Swartz, Ronald Conaway, Jingji Jin, Joan Conaway, Yong Cai, Patrice Waridel, Amanda W. Lund and Sachiko Hirosue and has published in prestigious journals such as Cell, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Francesca Capotosti

16 papers receiving 801 citations

Peers

Francesca Capotosti

IMMUN

ONCOL

PHYSI

Hongjun Jin China

Monica Baiula Italy

Kevin Becker United States

Sarah E. Poplawski United States

Guichao Zeng United States

Catarina Grandela Netherlands

Manveen K. Sethi United States

William Fieles United States

Emily F. Davis-Marcisak United States

Rachel M.A. Linger United States

Hongjun Jin China

Francesca Capotosti

465 ×1.2

123 ×0.4

IMMUN

167 ×0.7

ONCOL

53 ×0.3

PHYSI

26 ×0.3

Citations per year, relative to Francesca Capotosti Francesca Capotosti (= 1×) peers Hongjun Jin

Countries citing papers authored by Francesca Capotosti

Since Specialization

Citations

This map shows the geographic impact of Francesca Capotosti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Capotosti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Capotosti more than expected).

Fields of papers citing papers by Francesca Capotosti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Capotosti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Capotosti. The network helps show where Francesca Capotosti may publish in the future.

Co-authorship network of co-authors of Francesca Capotosti

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Capotosti. A scholar is included among the top collaborators of Francesca Capotosti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Capotosti. Francesca Capotosti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Varisco, Yvan, Francesca Capotosti, Paola Bezzi, et al.. (2025). Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity. PubMed. 14(1). 13–13. 3 indexed citations

Capotosti, Francesca. (2025). a-synuclein PET Imaging: From Clinical Utility in Multiple System Atrophy to the Possible Diagnosis of Parkinson’s Disease. Cells. 14(11). 834–834.

Smith, Ruben, Francesca Capotosti, Martin Schain, et al.. (2022). Initial clinical scans using [¹⁸F]ACI‐12589, a novel α‐synuclein PET‐tracer. Alzheimer s & Dementia. 18(S6). 8 indexed citations

Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2022). Discovery of [¹⁸F]ACI‐12589, a Novel and Promising PET‐Tracer for Alpha‐Synuclein. Alzheimer s & Dementia. 18(S6). 4 indexed citations

Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core. Bioorganic & Medicinal Chemistry. 52. 116528–116528. 7 indexed citations

Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer’s Disease and Other Tauopathies. Journal of Medicinal Chemistry. 64(17). 12808–12830. 13 indexed citations

Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2021). The development of [¹⁸F]ACI‐12589, a high affinity and selective alpha‐synuclein radiotracer, as a biomarker for Parkinson’s disease and other synucleinopathies. Alzheimer s & Dementia. 17(S5). 7 indexed citations

Gabellieri, Emanuele, Francesca Capotosti, Jérôme Molette, et al.. (2020). Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c’]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies. European Journal of Medicinal Chemistry. 204. 112615–112615. 6 indexed citations

Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2020). Developing a novel alpha‐synuclein positron emission tomography (PET) tracer for the diagnosis of synucleinopathies. Alzheimer s & Dementia. 16(S5). 5 indexed citations

10.

Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2019). Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2178–2189. 134 indexed citations

11.

Mueller, André, Heiko Kroth, Hanno Schieferstein, et al.. (2017). [P2–381]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. Alzheimer s & Dementia. 13(7S_Part_15). 6 indexed citations

12.

Mueller, André, Heiko Kroth, Hanno Schieferstein, et al.. (2017). [IC‐P‐192]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. Alzheimer s & Dementia. 13(7S_Part_3). 2 indexed citations

13.

Barret, Olivier, John Seibyl, Andrew Stephens, et al.. (2017). [IC‐01–05]: FIRST‐IN‐HUMAN PET STUDIES WITH THE NEXT GENERATION TAU AGENT 18‐F PI‐2620 IN ALZHEIMER's DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY, AND CONTROLS. Alzheimer s & Dementia. 13(7S_Part_1). 6 indexed citations

14.

Dubrot, Juan, Fernanda V. Durães, Lambert Potin, et al.. (2014). Lymph node stromal cells acquire peptide–MHCII complexes from dendritic cells and induce antigen-specific CD4+ T cell tolerance. The Journal of Experimental Medicine. 211(6). 1153–1166. 192 indexed citations

15.

Hirosue, Sachiko, Vidya Raghavan, Marcela Rincón-Restrepo, et al.. (2014). Steady-State Antigen Scavenging, Cross-Presentation, and CD8+ T Cell Priming: A New Role for Lymphatic Endothelial Cells. The Journal of Immunology. 192(11). 5002–5011. 174 indexed citations

16.

Capotosti, Francesca, Patrice Waridel, Yong Cai, et al.. (2011). O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1. Cell. 144(3). 376–388. 193 indexed citations

17.

Capotosti, Francesca, James J. Hsieh, & Winship Herr. (2007). Species Selectivity of Mixed-Lineage Leukemia/Trithorax and HCF Proteolytic Maturation Pathways. Molecular and Cellular Biology. 27(20). 7063–7072. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact